165 related articles for article (PubMed ID: 22273841)
41. De Novo Anti-HLA Antibodies After Heart Transplantation Are Associated With Adverse Events in the Long-term Follow-up of Cardiac Transplant Recipients.
Solé-González E; Mirabet S; Brossa V; López-López L; Rivas-Lasarte M; Capellades-Olivella H; Ginel-Iglesias AJ; Martorell-Pons J; Roig E
Transplant Proc; 2016 Nov; 48(9):3030-3032. PubMed ID: 27932139
[TBL] [Abstract][Full Text] [Related]
42. Monokine induced by IFN-gamma is a dominant factor directing T cells into murine cardiac allografts during acute rejection.
Miura M; Morita K; Kobayashi H; Hamilton TA; Burdick MD; Strieter RM; Fairchild RL
J Immunol; 2001 Sep; 167(6):3494-504. PubMed ID: 11544343
[TBL] [Abstract][Full Text] [Related]
43. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
[TBL] [Abstract][Full Text] [Related]
44. Prevention of obliterative airway disease in HLA-A2-transgenic tracheal allografts by neutralization of tumor necrosis factor.
Smith CR; Jaramillo A; Lu KC; Higuchi T; Kaleem Z; Mohanakumar T
Transplantation; 2001 Nov; 72(9):1512-8. PubMed ID: 11707738
[TBL] [Abstract][Full Text] [Related]
45. Gene transfer of immunomodulatory peptides correlates with heme oxygenase-1 induction and enhanced allograft survival.
DeBruyne LA; Magee JC; Buelow R; Bromberg JS
Transplantation; 2000 Jan; 69(1):120-8. PubMed ID: 10653390
[TBL] [Abstract][Full Text] [Related]
46. Real-time polymerase chain reaction analysis reveals an evolution of cytokine mRNA production in allograft acceptor mice.
Xia D; Sanders A; Shah M; Bickerstaff A; Orosz C
Transplantation; 2001 Sep; 72(5):907-14. PubMed ID: 11571458
[TBL] [Abstract][Full Text] [Related]
47. Donor-derived soluble HLA plasma levels can not be used to monitor graft rejection in heart transplant recipients.
Koelman CA; Vaessen LM; Balk AH; Weimar W; Doxiadis II; Claas FH
Transpl Immunol; 2000 Mar; 8(1):57-64. PubMed ID: 10834611
[TBL] [Abstract][Full Text] [Related]
48. Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejection.
Murphy B; Kim KS; Buelow R; Sayegh MH; Hancock WW
Transplantation; 1997 Jul; 64(1):14-9. PubMed ID: 9233694
[TBL] [Abstract][Full Text] [Related]
49. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts.
Barr ML; Cohen DJ; Benvenisty AI; Hardy M; Reemtsma K; Rose EA; Marboe CC; D'Agati V; Suciu-Foca N; Reed E
Transplant Proc; 1993 Feb; 25(1 Pt 1):262-4. PubMed ID: 8438294
[TBL] [Abstract][Full Text] [Related]
50. Indirect recognition and antibody production against a single mismatched HLA-A2-transgenic molecule precede the development of obliterative airway disease in murine heterotopic tracheal allografts.
Smith MA; Jaramillo A; SivaSai KS; Naziruddin B; Kaleem Z; Patterson GA; Mohanakumar T
Transplantation; 2002 Jan; 73(2):186-93. PubMed ID: 11821728
[TBL] [Abstract][Full Text] [Related]
51. Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection.
Gill JS; Landsberg D; Johnston O; Shapiro RJ; Magil AB; Wu V; Tinckam K; Keown P
Transplantation; 2010 Jan; 89(2):178-84. PubMed ID: 20098280
[TBL] [Abstract][Full Text] [Related]
52. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML
J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913
[TBL] [Abstract][Full Text] [Related]
53. Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody.
Salama AD; Delikouras A; Pusey CD; Cook HT; Bhangal G; Lechler RI; Dorling A
Am J Transplant; 2001 Sep; 1(3):260-9. PubMed ID: 12102260
[TBL] [Abstract][Full Text] [Related]
54. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation.
Hancock WW; Sayegh MH; Kwok CA; Weiner HL; Carpenter CB
Transplantation; 1993 May; 55(5):1112-8. PubMed ID: 8497891
[TBL] [Abstract][Full Text] [Related]
55. Current concepts in histocompatibility during heart transplant.
Picascia A; Grimaldi V; Zullo A; Infante T; Maiello C; Crudele V; Sessa M; Mancini FP; Napoli C
Exp Clin Transplant; 2012 Jun; 10(3):209-18. PubMed ID: 22631055
[TBL] [Abstract][Full Text] [Related]
56. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
57. Anti-HLA-A2-CAR Tregs prolong vascularized mouse heterotopic heart allograft survival.
Wagner JC; Ronin E; Ho P; Peng Y; Tang Q
Am J Transplant; 2022 Sep; 22(9):2237-2245. PubMed ID: 35434896
[TBL] [Abstract][Full Text] [Related]
58. Adiponectin inhibits allograft rejection in murine cardiac transplantation.
Okamoto Y; Christen T; Shimizu K; Asano K; Kihara S; Mitchell RN; Libby P
Transplantation; 2009 Oct; 88(7):879-83. PubMed ID: 19935458
[TBL] [Abstract][Full Text] [Related]
59. Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies.
Itabashi Y; Aikawa A; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Arai T; Kawamura T; Hamasaki Y; Sakai K; Shishido S
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):43-49. PubMed ID: 30777522
[TBL] [Abstract][Full Text] [Related]
60. CD4+ T Cell Help Is Mandatory for Naive and Memory Donor-Specific Antibody Responses: Impact of Therapeutic Immunosuppression.
Chen CC; Koenig A; Saison C; Dahdal S; Rigault G; Barba T; Taillardet M; Chartoire D; Ovize M; Morelon E; Defrance T; Thaunat O
Front Immunol; 2018; 9():275. PubMed ID: 29515582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
